Creative Edge Nutrition Inc. Appoints Dr. David L. Felten, M.D., Ph.D. to Board of Directors
April 23 2014 - 10:00AM
Marketwired
Creative Edge Nutrition Inc. Appoints Dr. David L. Felten, M.D.,
Ph.D. to Board of Directors
New Board Member Brings Extensive Scientific Research,
Integrative Medicine, and R&D Experience
MADISON HEIGHTS, MI--(Marketwired - Apr 23, 2014) - Creative
Edge Nutrition, Inc. (OTC Pink: FITX) (PINKSHEETS: FITX) today
announced the appointment of Dr. David L. Felten, M.D., Ph. D., to
its Board of Directors.
"On behalf of the Creative Edge Nutrition board of directors
& our management team, I would like to proudly introduce and
welcome Dr. David Felten to the Creative Edge
Nutrition Family," stated Bill Chaaban, President & CEO.
"We believe Dr. Felten's in-depth approach to creating specialized
treatments in integrative medicine coupled with his extensive
medical and board experience, fits directly in line with our
company growth plans. I believe his role is pivotal in our
continued efforts to create the infrastructure that not only sets
industry standards to a new level, but also demands it for patients
& patient-outcomes through his involvement in strategic
planning on behalf of responsible medicine."
John Germinario, Chairman of Creative Edge Nutrition said, "I
have had the pleasure of knowing David for almost fifteen years and
I continue to be overly impressed with his qualifications and
intellectual capacity in modern day medicine. With Bill's full
support and the board's unanimous vote on Dr. Felten's appointment,
it speaks volumes to the clear vision, focus, drive we uniformly
have to establishing the highest industry standards in medicinal
marijuana dedicated to access, accountability, quality and outcomes
based medicine."
Mr. Germinario further commented, "We look forward to having
David work along side our super star Sam Alawieh through his
mentorship in guiding our company's continued infrastructure
developments that is in line with our company vision. We are
incredibly excited about the synergy in talents and believe Dr.
Felten's world-class knowledge and skillset will improve our
financial position and shareholder equity."
As the Chief Medical Director, Dr. David L. Felten, M.D. will
join alongside our Chief Pharmacology & Acquisitions Officer,
Dr. Sam Alawieh, Pharm.D. to partake in the launch of a fully
operational medical board focused on good manufacturing practice,
good laboratory practice, good clinical practice, compliance,
vitamin, drug and naturally occurring pharmaceuticals research and
development, treatment modality algorithms, and outcomes based
reviews and analysis. Dr. Felten will bring scientific rigor and
the highest of medical standards to the development, production,
and distribution of all products from CEN Biotech.
Dr. David L. Felten was recently Vice President, Research, and
Medical Director of the Research Institute at Beaumont Health
System, and the founding Associate Dean for research at the Oakland
University William Beaumont School of Medicine. He oversaw the
Health System's research portfolio and actively participated in the
development and commercialization of Beaumont's intellectual
property. He established a state-of-the-art Core Molecular
Laboratory and BioBank at Beaumont, strengthened the Beaumont
Research Coordinating Center for oversight of multi-center clinical
trials, and oversaw the conduct of all clinical translational
research and basic research. Dr. Felten received a B.S. from the
Massachusetts Institute of Technology in 1969, an M.D. from the
University of Pennsylvania in 1973, and a Ph.D. in
anatomy/neurosciences through the Institute for Neurological
Sciences at the University of Pennsylvania in 1974. He has
received numerous honors and awards, including the John D. and
Catherine T. MacArthur Foundation Prize Fellowship, and two
separate 10-year MERIT Awards from institutes (Aging, Mental
Health) at the National Institutes of Health.
Previously, Dr. Felten was Dean of the School of Graduate
Medical Education at Seton Hall University in South Orange, NJ, and
was responsible for leadership of the residencies and fellowships
in 5 large NJ hospitals, as well as graduate programs in allied
health. He also served as Professor and then Chair of the
Department of Neurobiology and Anatomy at the University of
Rochester School of Medicine. Dr. Felten's research documented
direct connections between the nervous system and the immune
system, and established the foundations for the field of brain,
behavior, and immunity (psychoneuroimmunology), and integrative
medicine. He has published over 200 peer-reviewed publications
and reviews, a majority of which focus on the links between the
nervous system and the immune system, and the role these
connections play in health and disease. Dr. Felten has served
for many years on the National Board of Medical Examiners, helping
to prepare questions for the US Medical Licensure
Examinations. He also is author of the definitive neuroscience
atlas, Netter's Atlas of Neuroscience, now in preparation for the
third edition. He has served as the Chairman of the Scientific
and Medical Advisory Board for Australian Cancer Technology
(Avantogen), the Medingen Group, and The Clerisy Corporation, and
is active in identification, evaluation, and commercialization of
IP in medical and biological sciences, and biotechnology. He
brings the same demanding scientific and medical standards to the
development and understanding of products for commercialization as
he does for his own research investigations.
About CEN Biotech CEN Biotech, Inc. was established in 2013 as a
partially owned subsidiary of Creative Edge Nutrition (OTC Pink:
FITX) (PINKSHEETS: FITX) for the sole purpose of supplying the
Canadian public with pharmaceutical-grade medical cannabis under
the newly established Marihuana for Medical Purposes Regulations
(MMPR). CEN Biotech Inc. has submitted a comprehensive application
to become a licensed producer (LP) of dried marihuana for medicinal
purposes and has received a ready-to-build approval from Health
Canada. http://www.cenbiotechinc.com
About Creative Edge Nutrition, Inc. Creative Edge Nutrition is a
holding company and a Nutritional Supplement Company focused on
developing innovative, high quality supplements. The company offers
a broad spectrum of capsules, tablets, and powders, as well as
science based products in the principal categories of weight
management, nutrition challenges, energy and fitness. The Company
manufactures under strict GMP guidelines at GMP Certified and/or
FDA registered facilities. http://www.cenergynutrition.com and
https://www.facebook.com/CenergyNutrition
Contact: FOR INVESTOR RELATIONS William Swalm (212) 584-4342
Info@cenergynutrition.com
Creative Edge Nutrition (CE) (USOTC:FITX)
Historical Stock Chart
From Nov 2024 to Dec 2024
Creative Edge Nutrition (CE) (USOTC:FITX)
Historical Stock Chart
From Dec 2023 to Dec 2024